Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2004 2
2005 1
2006 1
2007 2
2008 1
2009 3
2010 2
2011 2
2012 2
2013 5
2014 4
2015 4
2016 4
2017 8
2018 4
2019 3
2020 1
2021 1
2022 2
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

45 results

Results by year

Filters applied: . Clear all
Page 1
The oral disposition index calculated from a meal tolerance test is a crucial indicator for evaluating differential normalization of postprandial glucose and triglyceride excursions in morbidly obese patients after laparoscopic sleeve gastrectomy.
Yamamoto Y, Togawa T, Sekine O, Ozamoto Y, Fuse J, Azuma C, Ito-Kobayashi J, Oe Y, Hagiwara A, Kobayashi M, Kitamura T, Iwanishi M, Shimatsu A, Kashiwagi A. Yamamoto Y, et al. Among authors: sekine o. Endocr J. 2023 Dec 28;70(12):1141-1157. doi: 10.1507/endocrj.EJ23-0241. Epub 2023 Oct 17. Endocr J. 2023. PMID: 37853621 Free article.
Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk.
Das Pradhan A, Glynn RJ, Fruchart JC, MacFadyen JG, Zaharris ES, Everett BM, Campbell SE, Oshima R, Amarenco P, Blom DJ, Brinton EA, Eckel RH, Elam MB, Felicio JS, Ginsberg HN, Goudev A, Ishibashi S, Joseph J, Kodama T, Koenig W, Leiter LA, Lorenzatti AJ, Mankovsky B, Marx N, Nordestgaard BG, Páll D, Ray KK, Santos RD, Soran H, Susekov A, Tendera M, Yokote K, Paynter NP, Buring JE, Libby P, Ridker PM; PROMINENT Investigators. Das Pradhan A, et al. N Engl J Med. 2022 Nov 24;387(21):1923-1934. doi: 10.1056/NEJMoa2210645. Epub 2022 Nov 5. N Engl J Med. 2022. PMID: 36342113 Clinical Trial.
Effects of a new 75 g glucose- and high fat-containing cookie meal test on postprandial glucose and triglyceride excursions in morbidly obese patients.
Yamamoto Y, Ozamoto Y, Kobayashi M, Tezuka Y, Azuma C, Sekine O, Ito-Kobayashi J, Washiyama M, Oe Y, Iwanishi M, Togawa T, Hagiwara A, Kitamura T, Shimatsu A, Kashiwagi A. Yamamoto Y, et al. Among authors: sekine o. Endocr J. 2022 Jun 28;69(6):689-703. doi: 10.1507/endocrj.EJ21-0615. Epub 2022 Jan 27. Endocr J. 2022. PMID: 35082201 Free article.
A Prospective, Open-Label Short-Term Pilot Study on Modification of the Skin Hydration Status During Treatment With a Sodium-Glucose Cotransporter-2 Inhibitor.
Tezuka Y, Sekine O, Hirano A, Hanada Y, Nakanishi I, Ariga M, Azuma C, Yamamoto Y, Ito-Kobayashi J, Washiyama M, Iwanishi M, Furuta M, Kanamori M, Shimatsu A, Kashiwagi A. Tezuka Y, et al. Among authors: sekine o. Diabetes Ther. 2021 Jan;12(1):431-440. doi: 10.1007/s13300-020-00950-7. Epub 2020 Oct 27. Diabetes Ther. 2021. PMID: 33108650 Free PMC article.
Efficacy of metformin on postprandial plasma triglyceride concentration by administration timing in patients with type 2 diabetes mellitus: A randomized cross-over pilot study.
Sato D, Morino K, Ogaku S, Tsuji A, Nishimura K, Sekine O, Ugi S, Maegawa H. Sato D, et al. Among authors: sekine o. J Diabetes Investig. 2019 Sep;10(5):1284-1290. doi: 10.1111/jdi.13016. Epub 2019 Feb 22. J Diabetes Investig. 2019. PMID: 30688410 Free PMC article. Clinical Trial.
Ipragliflozin, a sodium-glucose cotransporter 2 inhibitor, reduces bodyweight and fat mass, but not muscle mass, in Japanese type 2 diabetes patients treated with insulin: A randomized clinical trial.
Inoue H, Morino K, Ugi S, Tanaka-Mizuno S, Fuse K, Miyazawa I, Kondo K, Sato D, Ohashi N, Ida S, Sekine O, Yoshimura M, Murata K, Miura K, Arima H, Maegawa H; SUMS-ADDIT-1 Research group. Inoue H, et al. Among authors: sekine o. J Diabetes Investig. 2019 Jul;10(4):1012-1021. doi: 10.1111/jdi.12985. Epub 2019 Jan 21. J Diabetes Investig. 2019. PMID: 30536746 Free PMC article. Clinical Trial.
Lack of O-GlcNAcylation enhances exercise-dependent glucose utilization potentially through AMP-activated protein kinase activation in skeletal muscle.
Murata K, Morino K, Ida S, Ohashi N, Lemecha M, Park SY, Ishikado A, Kume S, Choi CS, Sekine O, Ugi S, Maegawa H. Murata K, et al. Among authors: sekine o. Biochem Biophys Res Commun. 2018 Jan 8;495(2):2098-2104. doi: 10.1016/j.bbrc.2017.12.081. Epub 2017 Dec 15. Biochem Biophys Res Commun. 2018. PMID: 29253568
45 results